Does ALIROCUMAB Cause Hospitalisation? 163 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 163 reports of Hospitalisation have been filed in association with ALIROCUMAB (Praluent). This represents 0.7% of all adverse event reports for ALIROCUMAB.
163
Reports of Hospitalisation with ALIROCUMAB
0.7%
of all ALIROCUMAB reports
10
Deaths
156
Hospitalizations
How Dangerous Is Hospitalisation From ALIROCUMAB?
Of the 163 reports, 10 (6.1%) resulted in death, 156 (95.7%) required hospitalization, and 3 (1.8%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 163 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which ALIROCUMAB Alternatives Have Lower Hospitalisation Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN